Table of Contents Table of Contents
Previous Page  902 / 1138 Next Page
Information
Show Menu
Previous Page 902 / 1138 Next Page
Page Background

Introduction of oligometastases (Morten)

Clinical evidence (Alejandra)

Phase I/II trials

Retrospective cohort studies

Selection of patients (Morten)

SBRT for oligo-metastases